Skip to content

Based on the patient reported outcome (PRO), the study on the postoperative symptom management system for the treatment of vulvar leukoplakia with focused ultrasound was established

Based on the patient reported outcome (PRO), the study on the postoperative symptom management system for the treatment of vulvar leukoplakia with focused ultrasound was established

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089897
Enrollment
Unknown
Registered
2024-09-19
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukoplakia vulva

Interventions

Patient self-reported outcome group:Based on the patients self-reported symptoms, the doctor intervenes according to the symptoms
Conventional group:No intervention, routine follow-up

Sponsors

Nanchong Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Women with symptoms of vulvar leukoplakia; 2. Vulvar biopsy confirmed vulvar leukoplakia; 3. Able and willing to fill in the electronic scale through mobile phone or tablet computer.

Exclusion criteria

Exclusion criteria: 1. Inoperable patients with serious diseases; 2. Vulvar biopsy confirmed malignancy; 3. Those who cannot understand the research content; 4. The subject seriously violated the study plan (continued failure to follow the doctor's advice, intentionally asked the agent to fill out the forms, and intentionally provided wrong PRO information); 5. The subjects themselves asked to withdraw from the study.

Design outcomes

Primary

MeasureTime frame
Subjective evaluation of CSS score;

Secondary

MeasureTime frame
Clinician objective CSS score;Cattaneo clinical signs and symptoms score;EQ-5D-5L Health Questionnaire;

Countries

China

Contacts

Public ContactTang Ying

Nanchong Central Hospital

18712853802@139.com+86 152 8170 8927

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026